Tolerance and efficacy of the mars system in patients with severe alcoholic hepatitis non-responder to steroids: A pilot study

被引：0
|
作者：
Boitard, Jeanne
Louvet, Alexandre
Bismuth, Benjamin
Dharancy, Sebastien
Wartel, Faustine
Canva, Valerie
Deltenre, Pierre
Jude, Brigitte
Fourrier, Francois
Mathurin, Philippe
机构：
[1] Ctr Hosp Reg & Univ Lille, Hop Huriez, F-59037 Lille, France
[2] INSERM, U 795, F-59037 Lille, France
[3] Hop Cardiol, F-59037 Lille, France
[4] Hop Salengro, Lille, France
来源：
HEPATOLOGY | 2007年 / 46卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
202
引用
收藏
页码：327A / 327A
页数：1
相关论文
共 50 条
  • [41] Low dose ribavirin (RBV) in combination interferon (IFN) for the treatment of hepatitis C non-responder and relapse patients.
    Bernstein, DE
    Khan, R
    Jeffers, LJ
    Reddy, KR
    Schiff, ER
    HEPATOLOGY, 1998, 28 (04) : 702A - 702A
  • [42] Effects of recombinant interleukin-2 and revaccination for hepatitis B in previously vaccinated, non-responder, chronic uraemic patients
    Mauri, JM
    Valles, M
    Bronsoms, J
    Mate, G
    Torguet, P
    Pascual, R
    Serra, D
    Piera, J
    Prim, J
    Lopez, P
    Cuixart, M
    Matas, M
    Buendia, B
    Mestre, M
    Profitos, J
    Gonzalez, A
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (04) : 729 - 732
  • [43] Safety and potential efficacy of etanercept in patients with alcoholic hepatitis: Analysis of a recently completed pilot study.
    Menon, KN
    Jamil, L
    Stadheim, L
    Kamath, PS
    Wiesner, RH
    Gores, GJ
    Peine, CJ
    Shah, V
    HEPATOLOGY, 2003, 38 (04) : 264A - 264A
  • [44] Effect of electroconvulsive therapy in repetitive transcranial magnetic stimulation non-responder MDD patients: a preliminary study
    Dannon, PN
    Grunhaus, L
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2001, 4 (03): : 265 - 268
  • [45] Dynamics of hepatitis C virus NS5A quasispecies during interferon and ribavirin therapy in responder and non-responder patients with genotype 1b chronic hepatitis C
    Puig-Basagoiti, F
    Forns, X
    Furcic, I
    Ampurdanés, S
    Giménez-Barcons, M
    Franco, S
    Sanchez-Tapias, JM
    Saiz, JC
    JOURNAL OF GENERAL VIROLOGY, 2005, 86 : 1067 - 1075
  • [46] Amantadine triple therapy for non-responder hepatitis C patients.: Clues for controversies (ANRS HC 03 BITRI)
    Maynard, M
    Pradat, P
    Bailly, F
    Rozier, F
    Nemoz, C
    Ahmed, SNS
    Adeleine, P
    Trépo, C
    JOURNAL OF HEPATOLOGY, 2006, 44 (03) : 484 - 490
  • [47] Daily use of ribavirin-interferon combination in earlier non-responder or relapser patients with chronic hepatitis C.
    Karasu, Z
    Gurakar, A
    Jazzar, A
    McMillon, G
    Hulagu, S
    Wright, H
    HEPATOLOGY, 1999, 30 (04) : 629A - 629A
  • [48] Immunization with the therapeutic hepatitis C virus (HCV) peptide vaccine IC41 in 66 chronic hepatitis C non-responder patients
    Manns, MP
    Berg, T
    Wedemeyer, H
    Hinrichsen, H
    Cholewinska, G
    Zeuzem, S
    Blum, H
    Buerger, V
    Klade, C
    Tauber, E
    Jelovcan, S
    Buschle, M
    Frisch, J
    HEPATOLOGY, 2004, 40 (04) : 251A - 251A
  • [49] LONG-TERM SURVIVAL IN PATIENTS WITH NON SEVERE ALCOHOLIC HEPATITIS
    Degre, D.
    Lemmers, A.
    Gustot, T.
    Marechal, R.
    Evrard, S.
    Adler, M.
    Le Moine, O.
    Deviere, J.
    Moreno, C.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S359 - S359
  • [50] Effect of interferon and ribavirin combined with amantadine in interferon and ribavirin non-responder patients with chronic hepatitis C (genotype 1)
    Dilek Oguz
    Bahattin Cicek
    Levent Filik
    Bulent Odemis
    Mesut Kilic
    Engin Altintas
    Neslihan Zengin
    Emin Altiparmak
    World Journal of Gastroenterology, 2005, (04) : 580 - 583
12345